PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.\', \'Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA.\', \'Berenson Cancer Center, West Hollywood, CA, USA.\', \'Division of Hematology and Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.\', \'KP BIOSTATS, LLC, Seattle, WA, USA.\', \'Providence Cedars-Sinai Tarzana Medical Center, Tarzana, CA, USA.\', \'ENT Group of Los Angeles, Tarzana, CA, USA.\', \'ONCOtherapeutics, West Hollywood, CA, USA.\', \'Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA. jberenson@berensoncancercenter.org.\', \'Berenson Cancer Center, West Hollywood, CA, USA. jberenson@berensoncancercenter.org.\', \'ONCOtherapeutics, West Hollywood, CA, USA. jberenson@berensoncancercenter.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41375-021-01354-7
?:hasPublicationType
?:journal
  • Leukemia
is ?:pmid of
?:pmid
?:pmid
  • 34326466
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.131
?:rankingScore_hIndex
  • 168
is ?:relation_isRelatedTo_publication of
?:title
  • Response to mRNA vaccination for COVID-19 among patients with multiple myeloma.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all